FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

40202911000001100: Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2068681000001115 Ontozry 150mg tablets (Arvelle Therapeutics UK) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2068691000001118 Ontozry 150mg tablets (Arvelle Therapeutics UK) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2194341000001116 Ontozry 150mg tablets (Angelini Pharma UK-I Limited) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2194351000001118 Ontozry 150mg tablets (Angelini Pharma UK-I Limited) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2503151000001114 Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2503161000001112 Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Is a Cenobamate 150mg tablets true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Is a Ontozry true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has specific active ingredient Cenobamate true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 14 tablet Has AMP True Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Inferred relationship Existential restriction modifier
Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has AMP True Ontozry 150mg tablets (Angelini Pharma UK-I Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start